HomeCompareARSN vs EPRT

ARSN vs EPRT: Dividend Comparison 2026

ARSN yields 666666.67% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARSN wins by $8.275235618773884e+34M in total portfolio value
10 years
ARSN
ARSN
● Live price
666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.275235618773884e+34M
Annual income
$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00
Full ARSN calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — ARSN vs EPRT

📍 ARSN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARSNEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARSN + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARSN pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARSN
Annual income on $10K today (after 15% tax)
$56,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, ARSN beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARSN + EPRT for your $10,000?

ARSN: 50%EPRT: 50%
100% EPRT50/50100% ARSN
Portfolio after 10yr
$4.137617809386942e+34M
Annual income
$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.97%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

ARSN
No analyst data
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARSN buys
0
EPRT buys
0
No recent congressional trades found for ARSN or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARSNEPRT
Forward yield666666.67%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$8.275235618773884e+34M$63.4K
Annual income after 10y$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$12,840.73
Total dividends collected$8.275075881065991e+34M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: ARSN vs EPRT ($10,000, DRIP)

YearARSN PortfolioARSN Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$66,677,367$66,666,666.67$11,205$505.18+$66.67MARSN
2$415,506,651,117$415,435,306,334.37$12,672$682.46+$415506.64MARSN
3$2,419,908,598,386,268$2,419,464,006,269,573.00$14,490$930.48+$2419908598.37MARSN
4$13,171,697,643,084,456,000$13,169,108,340,884,183,000.00$16,786$1,282.69+$13171697643084.44MARSN
5$67,004,927,492,790,120,000,000$66,990,833,776,312,020,000,000.00$19,753$1,791.56+$67004927492790120.00MARSN
6$318,562,277,003,514,840,000,000,000$318,490,581,731,097,560,000,000,000.00$23,677$2,541.64+$318562277003514871808.00MARSN
7$1,415,484,168,853,553,000,000,000,000,000$1,415,143,307,217,159,200,000,000,000,000.00$29,008$3,672.99+$1.415484168853553e+24MARSN
8$5,878,130,573,362,507,000,000,000,000,000,000$5,876,616,005,301,833,000,000,000,000,000,000.00$36,463$5,425.08+$5.878130573362507e+27MARSN
9$22,813,793,009,840,743,000,000,000,000,000,000,000$22,807,503,410,127,248,000,000,000,000,000,000,000.00$47,238$8,221.57+$2.2813793009840744e+31MARSN
10$82,752,356,187,738,840,000,000,000,000,000,000,000,000$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00$63,385$12,840.73+$8.275235618773884e+34MARSN

ARSN vs EPRT: Complete Analysis 2026

ARSNStock

Aureus Incrated, an exploration stage company, develops and explores for mineral properties in Nevada and Montana. It holds interest in the Keene Placer claims that cover an area of 19.67 acres located in Broadwater County, Montana; and Western Star Lode claim and Mill site, which covers an area of 13.22 acres located in the Confederate Gulch mining district in Broadwater County, Montana. The company was founded in 2013 and is based in Atlanta, Georgia. Aureus Incorporated is a subsidiary of Maverick, LLC.

Full ARSN Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this ARSN vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARSN vs SCHDARSN vs JEPIARSN vs OARSN vs KOARSN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.